US FDA Has Model Drug Facts Labels For OTC Naloxone, Needs Switch Proposals

by Brian Shim | Nov 2, 2022 | News

OTC Naloxone One Step Closer as Harm Reduction Therapeutics Initiates a Rolling Submission of its New Drug Application to U.S. FDA for RiVive™ for Emergency Treatment of Opioid Overdose

by Brian Shim | Oct 11, 2022 | News

Harm Reduction Therapeutics Signs Commercial Supply Agreement for Fast Tracked Naloxone Nasal Spray to Reverse Opioid Overdoses

by Brian Shim | Aug 11, 2022 | News

Harm Reduction Therapeutics Announces that its Naloxone Nasal Spray Met its Primary Endpoints in a Phase 1 Clinical Trial

by Brian Shim | Mar 1, 2022 | News

What’s Taking So Long for Naloxone to Be Made Available Over the Counter?

by Brian Shim | Jan 18, 2019 | News